Skip to main content
SpringerLink
Log in

Transcatheter Aortic Valve Replacement Planning with Cardiac CT: Protocols and Practical Tips

  • Cardiac Computed Tomography (TC Villines, Section Editor)
  • Published:
Current Cardiovascular Imaging Reports Aims and scope Submit manuscript

Abstract

The advent of transcatheter aortic valve replacement (TAVR) has provided a feasible treatment option for high surgical risk patients with severe aortic stenosis and increasingly is also being implemented in intermediate- and low-risk patients. As such, pre-procedure planning with multidetector computed tomography (MDCT) is now widespread and represents an integral component in the success of this treatment with contributions to transcatheter valve selection, sizing and identification of adverse annular root features. This review provides insight into the CT protocols utilised to acquire meaningful data for analysis, as well as methods, practical tips and rationale for recommended aortic root and aortoiliofemoral measurements.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin 3rd JP, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57–e185.

    Article  PubMed  Google Scholar 

  2. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.

    Article  CAS  PubMed  Google Scholar 

  3. Iung B, Vahanian A. Degenerative calcific aortic stenosis: a natural history. Heart. 2012;98 Suppl 4:iv7-13.

    Article  PubMed  Google Scholar 

  4. Osnabrugge RL, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62(11):1002–12.

    Article  PubMed  Google Scholar 

  5. Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26(24):2714–20.

    Article  PubMed  Google Scholar 

  6. Otto CM, Mickel MC, Kennedy JW, Alderman EL, Bashore TM, Block PC, et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation. 1994;89(2):642–50.

    Article  CAS  PubMed  Google Scholar 

  7. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.

    Article  CAS  PubMed  Google Scholar 

  8. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790–8. Randomized, multicenter, non-inferiority trial for the evaluation of self expanding transcatheter aortic valves in high risk surgical candidates compared with SAVR. Primary endpoint of rate of death at 1 year from any cause was lower in the TAVR population with an absolute reduction of risk by 4.9 %.

  9. Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2485–91.

    Article  PubMed  Google Scholar 

  10. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2477–84.

    Article  PubMed  Google Scholar 

  11. S K, editor. Clinical and echocardiographic outcomes at 30 days with the SAPIEN 3 TAVR system in inoperable, high-risk and intermediate-risk AS patients. American College of Cardiology; 2015 March 14–16; San Diego, USA.

  12. Moss RR, Ivens E, Pasupati S, Humphries K, Thompson CR, Munt B, et al. Role of echocardiography in percutaneous aortic valve implantation. JACC Cardiovasc Imaging. 2008;1(1):15–24.

    Article  PubMed  Google Scholar 

  13. Pontone G, Andreini D, Bartorelli AL, Bertella E, Cortinovis S, Mushtaq S, et al. Aortic annulus area assessment by multidetector computed tomography for predicting paravalvular regurgitation in patients undergoing balloon-expandable transcatheter aortic valve implantation: a comparison with transthoracic and transesophageal echocardiography. Am Heart J. 2012;164(4):576–84.

    Article  PubMed  Google Scholar 

  14. Ng AC, Delgado V, van der Kley F, Shanks M, van de Veire NR, Bertini M, et al. Comparison of aortic root dimensions and geometries before and after transcatheter aortic valve implantation by 2- and 3-dimensional transesophageal echocardiography and multislice computed tomography. Circ Cardiovasc Imaging. 2010;3(1):94–102.

    Article  PubMed  Google Scholar 

  15. Kodali S, Pibarot P, Douglas PS, Williams M, Xu K, Thourani V, et al. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J. 2015;36(7):449–56.

    Article  PubMed  Google Scholar 

  16. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366(18):1686–95.

    Article  CAS  PubMed  Google Scholar 

  17. Willson AB, Webb JG, Labounty TM, Achenbach S, Moss R, Wheeler M, et al. 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J Am Coll Cardiol. 2012;59(14):1287–94. The first study to suggest aortic annular measurements by MDCT allow prediction of moderate or severe PAR post TAVR. An optimal oversizing by area percentage was suggested to minimise PAR, while balancing the risk of annular rupture.

  18. Binder RK, Webb JG, Willson AB, Urena M, Hansson NC, Norgaard BL, et al. The impact of integration of a multidetector computed tomography annulus area sizing algorithm on outcomes of transcatheter aortic valve replacement: a prospective, multicenter, controlled trial. J Am Coll Cardiol. 2013;62(5):431–8.

    Article  PubMed  Google Scholar 

  19. Mylotte D, Dorfmeister M, Elhmidi Y, Mazzitelli D, Bleiziffer S, Wagner A, et al. Erroneous measurement of the aortic annular diameter using 2-dimensional echocardiography resulting in inappropriate CoreValve size selection: a retrospective comparison with multislice computed tomography. JACC Cardiovasc Interv. 2014;7(6):652–61.

    Article  PubMed  Google Scholar 

  20. Gooley RP, Cameron JD, Meredith IT. Assessment of the geometric interaction between the lotus transcatheter aortic valve prosthesis and the native ventricular aortic interface by 320-multidetector computed tomography. JACC Cardiovasc Interv. 2015;8(5):740–9.

    Article  PubMed  Google Scholar 

  21. Meredith IT, Worthley SG, Whitbourn RJ, Antonis P, Montarello JK, Newcomb AE, et al. Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study. EuroIntervention. 2014;9(11):1264–70.

    Article  PubMed  Google Scholar 

  22. Meredith Am IT, Walters DL, Dumonteil N, Worthley SG, Tchetche D, Manoharan G, et al. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. J Am Coll Cardiol. 2014;64(13):1339–48. 30 day outcomes from a prospective, multicenter, single arm trial evaluating the safety and efficacy of repositionable and retrievable transcatheter valves in the treatment of severe aortic stenosis in the high risk population.

  23. Achenbach S, Delgado V, Hausleiter J, Schoenhagen P, Min JK, Leipsic JA. SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr. 2012;6(6):366–80.

    Article  PubMed  Google Scholar 

  24. Ghafourian K, Younes D, Simprini LA, Weigold WG, Weissman G, Taylor AJ. Scout view X-ray attenuation versus weight-based selection of reduced peak tube voltage in cardiac CT angiography. JACC Cardiovasc Imaging. 2012;5(6):589–95.

    Article  PubMed  Google Scholar 

  25. Holmes Jr DR, Brennan JM, Rumsfeld JS, Dai D, O’Brien SM, Vemulapalli S, et al. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA. 2015;313(10):1019–28.

    Article  CAS  PubMed  Google Scholar 

  26. Stevens PE, Farmer CK, Hallan SI. The primary care physician: nephrology interface for the identification and treatment of chronic kidney disease. J Nephrol. 2010;23(1):23–32.

    PubMed  Google Scholar 

  27. Gargiulo G, Capodanno D, Sannino A, Perrino C, Capranzano P, Stabile E, et al. Moderate and severe preoperative chronic kidney disease worsen clinical outcomes after transcatheter aortic valve implantation: meta-analysis of 4992 patients. Circ Cardiovasc Interv. 2015;8(2):e002220.

    Article  PubMed  Google Scholar 

  28. Jochheim D, Schneider VS, Schwarz F, Kupatt C, Lange P, Reiser M, et al. Contrast-induced acute kidney injury after computed tomography prior to transcatheter aortic valve implantation. Clin Radiol. 2014;69(10):1034–8.

    Article  CAS  PubMed  Google Scholar 

  29. Azzalini L, Abbara S, Ghoshhajra BB. Ultra-low contrast computed tomographic angiography (CTA) with 20-mL total dose for transcatheter aortic valve implantation (TAVI) planning. J Comput Assist Tomogr. 2014;38(1):105–9.

    Article  PubMed  Google Scholar 

  30. Wuest W, Anders K, Schuhbaeck A, May MS, Gauss S, Marwan M, et al. Dual source multidetector CT-angiography before Transcatheter Aortic Valve Implantation (TAVI) using a high-pitch spiral acquisition mode. Eur Radiol. 2012;22(1):51–8.

    Article  CAS  PubMed  Google Scholar 

  31. Geyer LL, De Cecco CN, Schoepf UJ, Silverman JR, Krazinski AW, Bamberg F, et al. Low-volume contrast medium protocol for comprehensive cardiac and aortoiliac CT assessment in the context of transcatheter aortic valve replacement. Acad Radiol. 2015;22(9):1138–46.

    Article  PubMed  Google Scholar 

  32. Leipsic J, Wood D, Manders D, Nietlispach F, Masson JB, Mayo J, et al. The evolving role of MDCT in transcatheter aortic valve replacement: a radiologists’ perspective. AJR Am J Roentgenol. 2009;193(3):W214–9.

    Article  PubMed  Google Scholar 

  33. Spagnolo P, Giglio M, Di Marco D, Latib A, Besana F, Chieffo A, et al. Feasibility of ultra-low contrast 64-slice computed tomography angiography before transcatheter aortic valve implantation: a real-world experience. Eur Heart J Cardiovasc Imaging. 2015.

  34. Bernhardt P, Rodewald C, Seeger J, Gonska B, Buckert D, Radermacher M, et al. Non-contrast-enhanced magnetic resonance angiography is equal to contrast-enhanced multislice computed tomography for correct aortic sizing before transcatheter aortic valve implantation. Clin Res Cardiol. 2015;105:273–8.

    Article  PubMed  Google Scholar 

  35. Gopal A, Grayburn PA, Mack M, Chacon I, Kim R, Montenegro D, et al. Noncontrast 3D CMR imaging for aortic valve annulus sizing in TAVR. JACC Cardiovasc Imaging. 2015;8(3):375–8.

    Article  PubMed  Google Scholar 

  36. Pontone G, Andreini D, Bartorelli AL, Bertella E, Mushtaq S, Gripari P, et al. Comparison of accuracy of aortic root annulus assessment with cardiac magnetic resonance versus echocardiography and multidetector computed tomography in patients referred for transcatheter aortic valve implantation. Am J Cardiol. 2013;112(11):1790–9.

    Article  PubMed  Google Scholar 

  37. Khalique OK, Kodali SK, Paradis JM, Nazif TM, Williams MR, Einstein AJ, et al. Aortic annular sizing using a novel 3-dimensional echocardiographic method: use and comparison with cardiac computed tomography. Circ Cardiovasc Imaging. 2014;7(1):155–63.

    Article  PubMed  Google Scholar 

  38. Schmidkonz C, Marwan M, Klinghammer L, Mitschke M, Schuhbaeck A, Arnold M, et al. Interobserver variability of CT angiography for evaluation of aortic annulus dimensions prior to transcatheter aortic valve implantation (TAVI). Eur J Radiol. 2014;83(9):1672–8.

    Article  CAS  PubMed  Google Scholar 

  39. Sucha D, Tuncay V, Prakken NH, Leiner T, van Ooijen PM, Oudkerk M, et al. Does the aortic annulus undergo conformational change throughout the cardiac cycle? A systematic review. Eur Heart J Cardiovasc Imaging. 2015.

  40. Blanke P, Russe M, Leipsic J, Reinohl J, Ebersberger U, Suranyi P, et al. Conformational pulsatile changes of the aortic annulus: impact on prosthesis sizing by computed tomography for transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2012;5(9):984–94.

    Article  PubMed  Google Scholar 

  41. Murphy DT, Blanke P, Alaamri S, Naoum C, Rubinshtein R, Pache G, et al. Dynamism of the aortic annulus: Effect of diastolic versus systolic CT annular measurements on device selection in transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr. 2015.

  42. Blanke P, Schoepf UJ, Leipsic JA. CT in transcatheter aortic valve replacement. Radiology. 2013;269(3):650–69.

    Article  PubMed  Google Scholar 

  43. Kasel AM, Cassese S, Bleiziffer S, Amaki M, Hahn RT, Kastrati A, et al. Standardized imaging for aortic annular sizing. JACC Cardiovasc Imaging. 2013;6(2):249–62.

    Article  PubMed  Google Scholar 

  44. Lou J, Obuchowski NA, Krishnaswamy A, Popovic Z, Flamm SD, Kapadia SR, et al. Manual, semiautomated, and fully automated measurement of the aortic annulus for planning of transcatheter aortic valve replacement (TAVR/TAVI): analysis of interchangeability. J Cardiovasc Comput Tomogr. 2015;9(1):42–9.

    Article  PubMed  Google Scholar 

  45. Buellesfeld L, Stortecky S, Heg D, Gloekler S, Meier B, Wenaweser P, et al. Extent and distribution of calcification of both the aortic annulus and the left ventricular outflow tract predict aortic regurgitation after transcatheter aortic valve replacement. EuroIntervention. 2014;10(6):732–8.

    Article  PubMed  Google Scholar 

  46. Azzalini L, Ghoshhajra BB, Elmariah S, Passeri JJ, Inglessis I, Palacios IF, et al. The aortic valve calcium nodule score (AVCNS) independently predicts paravalvular regurgitation after transcatheter aortic valve replacement (TAVR). J Cardiovasc Comput Tomogr. 2014;8(2):131–40.

    Article  PubMed  Google Scholar 

  47. Ewe SH, Ng AC, Schuijf JD, van der Kley F, Colli A, Palmen M, et al. Location and severity of aortic valve calcium and implications for aortic regurgitation after transcatheter aortic valve implantation. Am J Cardiol. 2011;108(10):1470–7.

    Article  CAS  PubMed  Google Scholar 

  48. Colli A, D’Amico R, Kempfert J, Borger MA, Mohr FW, Walther T. Transesophageal echocardiographic scoring for transcatheter aortic valve implantation: impact of aortic cusp calcification on postoperative aortic regurgitation. J Thorac Cardiovasc Surg. 2011;142(5):1229–35.

    Article  PubMed  Google Scholar 

  49. Khalique OK, Hahn RT, Gada H, Nazif TM, Vahl TP, George I, et al. Quantity and location of aortic valve complex calcification predicts severity and location of paravalvular regurgitation and frequency of post-dilation after balloon-expandable transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2014;7(8):885–94.

    Article  PubMed  Google Scholar 

  50. Hansson NC, Norgaard BL, Barbanti M, Nielsen NE, Yang TH, Tamburino C, et al. The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr. 2015;9(5):382–92.

    Article  PubMed  Google Scholar 

  51. Barbanti M, Yang TH, Rodes Cabau J, Tamburino C, Wood DA, Jilaihawi H, et al. Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation. 2013;128(3):244–53. The largest series of post TAVR annular rupture patients with caliper matched control group, identifying moderate or severe LVOT calcification and >20% area oversizing as significantly associated with increased risk of annular rupture.

  52. Hamdan A, Guetta V, Klempfner R, Konen E, Raanani E, Glikson M, et al. Inverse relationship between membranous septal length and the risk of atrioventricular block in patients undergoing transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2015;8(9):1218–28.

    Article  PubMed  Google Scholar 

  53. Chen M, Feng Y, Mazzitelli D, Tang H, Wei X, Zhao ZG, et al. Transcatheter aortic valve implantation in a patient with severe bicuspid aortic valve stenosis and ascending aortic aneurysm. JACC Cardiovasc Interv. 2014;7(7):e83–4.

    Article  PubMed  Google Scholar 

  54. Mylotte D, Lefevre T, Sondergaard L, Watanabe Y, Modine T, Dvir D, et al. Transcatheter aortic valve replacement in bicuspid aortic valve disease. J Am Coll Cardiol. 2014;64(22):2330–9.

    Article  PubMed  Google Scholar 

  55. Sievers HH, Schmidtke C. A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg. 2007;133(5):1226–33.

    Article  PubMed  Google Scholar 

  56. Ribeiro HB, Webb JG, Makkar RR, Cohen MG, Kapadia SR, Kodali S, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol. 2013;62(17):1552–62. The largest multicenter study to date evaluating anatomical, procedural and management characteristics associated with TAVR related coronary artery occlusion. Low left main ostial height, shallow sinuses of Valsalva, female sex, BEV and existing valve prosthesis were identified more frequently in this subgroup.

  57. Harris BS, De Cecco CN, Schoepf UJ, Steinberg DH, Bayer RR, Krazinski AW, et al. Dual-source CT imaging to plan transcatheter aortic valve replacement: accuracy for diagnosis of obstructive coronary artery disease. Radiology. 2015;275(1):80–8.

    Article  PubMed  Google Scholar 

  58. Andreini D, Pontone G, Mushtaq S, Bartorelli AL, Ballerini G, Bertella E, et al. Diagnostic accuracy of multidetector computed tomography coronary angiography in 325 consecutive patients referred for transcatheter aortic valve replacement. Am Heart J. 2014;168(3):332–9.

    Article  PubMed  Google Scholar 

  59. Chieffo A, Giustino G, Spagnolo P, Panoulas VF, Montorfano M, Latib A, et al. Routine screening of coronary artery disease with computed tomographic coronary angiography in place of invasive coronary angiography in patients undergoing transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2015;8(7), e002025.

    PubMed  Google Scholar 

  60. Samim M, Stella PR, Agostoni P, Kluin J, Ramjankhan F, Budde RP, et al. Automated 3D analysis of pre-procedural MDCT to predict annulus plane angulation and C-arm positioning: benefit on procedural outcome in patients referred for TAVR. JACC Cardiovasc Imaging. 2013;6(2):238–48.

    Article  PubMed  Google Scholar 

  61. Arnold M, Achenbach S, Pfeiffer I, Ensminger S, Marwan M, Einhaus F, et al. A method to determine suitable fluoroscopic projections for transcatheter aortic valve implantation by computed tomography. J Cardiovasc Comput Tomogr. 2012;6(6):422–8.

    Article  PubMed  Google Scholar 

  62. Okuyama K, Jilaihawi H, Kashif M, Takahashi N, Chakravarty T, Pokhrel H, et al. Transfemoral access assessment for transcatheter aortic valve replacement: evidence-based application of computed tomography over invasive angiography. Circ Cardiovasc Imaging. 2015;8(1):doi: 10.1161/CIRCIMAGING.114.001995.

  63. Hayashida K, Lefevre T, Chevalier B, Hovasse T, Romano M, Garot P, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv. 2011;4(8):851–8.

    Article  PubMed  Google Scholar 

  64. Frohlich GM, Baxter PD, Malkin CJ, Scott DJ, Moat NE, Hildick-Smith D, et al. Comparative survival after transapical, direct aortic, and subclavian transcatheter aortic valve implantation (data from the UK TAVI Registry). Am J Cardiol. 2015;116(10):1555–9.

    Article  PubMed  Google Scholar 

  65. Pache G, Blanke P, Zeh W, Jander N. Cusp thrombosis after transcatheter aortic valve replacement detected by computed tomography and echocardiography. Eur Heart J. 2013;34(46):3546.

    Article  PubMed  Google Scholar 

  66. Tay EL, Gurvitch R, Wijeysinghe N, Nietlispach F, Wood D, Allard M, et al. Valve thrombosis after transcatheter heart valve implantation. EuroIntervention. 2011;7(1):170–1.

    Article  PubMed  Google Scholar 

  67. Latib A, Messika-Zeitoun D, Maisano F, Himbert D, Agricola E, Brochet E, et al. Reversible Edwards Sapien XT dysfunction due to prosthesis thrombosis presenting as early structural deterioration. J Am Coll Cardiol. 2013;61(7):787–9.

    Article  PubMed  Google Scholar 

  68. De Marchena E, Mesa J, Pomenti S, Marin YKC, Marincic X, Yahagi K, et al. Thrombus formation following transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2015;8(5):728–39.

    Article  PubMed  Google Scholar 

  69. Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, de Backer O, et al. Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med. 2015;373:2015–24. Analysis of CT data from the PORTICO IDE trial and RESOLVE and SAVORY registries reporting the detection of reduced prosthetic valve leaflet motion, postulated due to leaflet thrombosis. Observed resolution or absence with therapeutic anticoagulation. Uncertain clinical implications with no significant difference in stroke or TIA.

  70. Webb J, Gerosa G, Lefevre T, Leipsic J, Spence M, Thomas M, et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol. 2014;64(21):2235–43. Prospective, mutinational, mulitcenter trial demonstrating some of the lowest reported rates of transcatheter aortic valve replacement complications including paravalvular regurgitation, stroke and mortality, using a 3 rd generation balloon expandable prosthetic valve.

  71. Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. Journal of the American College of Cardiology. 2014;63(19):1972–81. Non randomized, prospective study evaluating patients with severe aortic stenosis at extreme surgical risk undergoing TAVR with self expanding prosthetic valve. Lower rate of all cause mortality or major stroke compared with objective performance goal.

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, St. Paul’s Hospital, 1081 Burrard St, Vancouver, BC, V6Z 1Y6, Canada

    Jeanette Soon, Christopher Naoum, Philipp Blanke & Jonathon Leipsic

Authors
  1. Jeanette Soon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher Naoum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Philipp Blanke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jonathon Leipsic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathon Leipsic.

Ethics declarations

Conflict of Interest

JS and CN declare that they have no conflicts of interest. PB reports consultancy for Edwards Lifesciences, Tendyne Holdings, Circle Imaging and Neovasc and speaker’s fees from Edwards Lifesciences, outside the submitted work. JL reports consultancy, grants to his institution (Corelab) and speaker’s fees from Edwards Lifesciences, outside the submitted work.

Human and Animal Rights and Informed Consent

With regard to the authors’ research cited in this paper, all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. In addition, all applicable international, national and/or institutional guidelines for the care and use of animals were followed.

Additional information

This article is part of the Topical Collection on Cardiac Computed Tomography

Appendix

Appendix

Table 2 GE revolution CT
Full size table
Table 3 Revolution discovery ct (revolution hd, revolution gsi), discovery ct750 hd, discovery ct, optima ct660, revolution evo and lightspeed vct scanner platforms
Full size table
Table 4 Siemens somatom definition flash and somatom force
Full size table

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Soon, J., Naoum, C., Blanke, P. et al. Transcatheter Aortic Valve Replacement Planning with Cardiac CT: Protocols and Practical Tips. Curr Cardiovasc Imaging Rep 9, 15 (2016). https://doi.org/10.1007/s12410-016-9376-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s12410-016-9376-y

Keywords

Search

Navigation